Physician profile
John C Theriot
NPI 1871554402
$1,296.06
in general payments reported to CMS, 2019-2025
11 companies · $348 in 2025
The $348 reported for 2025 was more than what 86% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.38 · 2020: $142 · 2021: $16.33 · 2022: $282 · 2023: $190 · 2024: $218 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574 · Gift: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.61 |
| Gift | $182.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $374.96 | 2022-2025 | Opalescence |
| Envista Holdings Corporation | $250.52 | 2024-2025 | Endodontics, Harmonize, Optibond Xtr |
| Ivoclar Vivadent, INC. | $108.45 | 2020 | |
| Dentsply Sirona INC | $108.12 | 2019-2023 | Cavitron |
| Glaxosmithkline, LLC. | $100.00 | 2025 | Shingrix, Arexvy |
| Zimmer Biomet Holdings, INC. | $99.33 | 2019-2020 | |
| Kerr Corporation | $85.99 | 2023 | Endodontics |
| Nobel Biocare USA | $85.99 | 2023 | Nobelactive |
| Biohorizons Implant Systems INC. | $35.52 | 2021-2024 | Biohorizons |
| Henry Schein, INC. | $33.66 | 2024 | Su-Por Surgical Implant |
| Solventum Corporation | $13.52 | 2025 | 3m Relyx, 3m Espe Filtek Supreme Ultra Universal Restorative, Clarity Aligners |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Theriot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.